Nutrigenomics Center Varna, Medical University, Varna, Bulgaria.
EPMA J. 2011 Sep;2(3):271-6. doi: 10.1007/s13167-011-0099-5. Epub 2011 Jul 14.
Bariatric surgery is a component of the multimodal treatment of obesity, which consists of multidisciplinary evaluation and diagnosis, conservative and surgical treatments, and lifelong follow-up care. The current guideline extends the BMI-based spectrum of indications that was previously proposed (BMI greater than 40 kg/m(2), or greater than 35 kg/m(2) with secondary diseases) by eliminating age limits, as well as most of the contraindications. A prerequisite for surgery is that a structured, conservative weight-loss program has failed or is considered to be futile. Type 2 diabetes is now considered an independent indication under clinical study conditions for patients whose BMI is less than 35 kg/m(2) (metabolic surgery). The standard laparoscopic techniques are gastric banding, gastric bypass, sleeve gastrectomy, and biliopancreatic diversion. The choice of procedures is based on knowledge of the results, long-term effects, complications, and individual circumstances. Structured lifelong follow-up should be provided and should, in particular, prevent metabolic deficiencies.
减重手术是肥胖多模式治疗的组成部分,包括多学科评估和诊断、保守和手术治疗以及终身随访护理。当前的指南通过消除年龄限制以及大多数禁忌证,扩展了之前提出的基于 BMI 的适应证范围(BMI 大于 40kg/m²,或 BMI 大于 35kg/m² 伴有继发性疾病)。手术的前提是经过结构化的、保守的减重方案治疗失败或被认为无效。在临床研究条件下,对于 BMI 小于 35kg/m²(代谢手术)且患有 2 型糖尿病的患者,该疾病被视为独立适应证。标准的腹腔镜技术包括胃束带术、胃旁路术、袖状胃切除术和胆胰分流术。手术方式的选择基于对结果、长期效果、并发症和个体情况的了解。应提供结构化的终身随访,特别是应预防代谢不足。